Evidence map›Paper›PMID 37478177›Full record

ArticleScience advances2023

Scalable biomimetic sensing system with membrane receptor dual-monolayer probe and graphene transistor arrays.

Rui Qing, Mantian Xue, Jiayuan Zhao, Lidong Wu, Andreas Breitwieser, Eva Smorodina, Thomas Schubert, Giovanni Azzellino, David Jin, Jing Kong and 3 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Design of a water-soluble CD20 antigen with computational epitope scaffolding.Protein science : a publication of the Protein Society · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Rui QingState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0000-0002-7952-2295
Mantian XueDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.ORCID 0000-0001-5396-2674
Jiayuan ZhaoResearch Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Lidong WuChinese Academy of Fishery Sciences, Beijing 100141, China.ORCID 0000-0002-6397-6516
Andreas BreitwieserDepartment of Bionanosciences (DBNS), BOKU-University of Natural Resources and Life Sciences, Vienna, Austria.ORCID 0000-0001-6568-5299
Eva SmorodinaDepartment of Immunology, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID 0000-0002-5457-5163
Thomas Schubert2bind GmbH, Am BioPark 11, 93053 Regensburg, Germany.
Giovanni AzzellinoResearch Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
David JinAvalon GloboCare Corp., Freehold, NJ 07728, USA.
Jing KongResearch Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.ORCID 0000-0003-0551-1208
Tomás PalaciosDepartment of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.ORCID 0000-0002-2190-563X
Uwe B SleytrDepartment of Bionanosciences (DBNS), BOKU-University of Natural Resources and Life Sciences, Vienna, Austria.ORCID 0000-0002-1425-9860
Shuguang ZhangMIT Media Lab, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.ORCID 0000-0002-3856-3752
Massachusetts Institute of Technology · USBOKU University · ATAvalon Pharma (United States) · USChinese Academy of Fishery Sciences · CNOslo University Hospital · NOShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Affinity-based biosensing can enable point-of-care diagnostics and continuous health monitoring, which commonly follows bottom-up approaches and is inherently constrained by bioprobes' intrinsic properties, batch-to-batch consistency, and stability in biofluids. We present a biomimetic top-down platform to circumvent such difficulties by combining a "dual-monolayer" biorecognition construct with graphene-based field-effect-transistor arrays. The construct adopts redesigned water-soluble membrane receptors as specific sensing units, positioned by two-dimensional crystalline S-layer proteins as dense antifouling linkers guiding their orientations. Hundreds of transistors provide statistical significance from transduced signals. System feasibility was demonstrated with rSbpA-ZZ/CXCR4

Indexed as

Biosensing TechniquesGraphiteBiomimeticsElectricityHumansTransistors, ElectronicGraphite

Identifiers

PMID37478177
PMCPMC10361598
OpenAlexW4385059687

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.